JP6816098B2 - 粘膜炎症を抑制するためのイガイ接着タンパク質生成物及びその使用 - Google Patents

粘膜炎症を抑制するためのイガイ接着タンパク質生成物及びその使用 Download PDF

Info

Publication number
JP6816098B2
JP6816098B2 JP2018501271A JP2018501271A JP6816098B2 JP 6816098 B2 JP6816098 B2 JP 6816098B2 JP 2018501271 A JP2018501271 A JP 2018501271A JP 2018501271 A JP2018501271 A JP 2018501271A JP 6816098 B2 JP6816098 B2 JP 6816098B2
Authority
JP
Japan
Prior art keywords
map
treatment
patients
inflammation
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018501271A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019501108A (ja
JP2019501108A5 (enExample
Inventor
ガオ，ミン
インゲマル サミュエルソン，ベンクト
インゲマル サミュエルソン，ベンクト
Original Assignee
ジャンイン ベンクト アイ サミュエルソン インスティテュート オブ ライフ サイエンス カンパニー リミテッド
ジャンイン ベンクト アイ サミュエルソン インスティテュート オブ ライフ サイエンス カンパニー リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジャンイン ベンクト アイ サミュエルソン インスティテュート オブ ライフ サイエンス カンパニー リミテッド, ジャンイン ベンクト アイ サミュエルソン インスティテュート オブ ライフ サイエンス カンパニー リミテッド filed Critical ジャンイン ベンクト アイ サミュエルソン インスティテュート オブ ライフ サイエンス カンパニー リミテッド
Publication of JP2019501108A publication Critical patent/JP2019501108A/ja
Publication of JP2019501108A5 publication Critical patent/JP2019501108A5/ja
Application granted granted Critical
Publication of JP6816098B2 publication Critical patent/JP6816098B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
JP2018501271A 2015-08-14 2016-08-15 粘膜炎症を抑制するためのイガイ接着タンパク質生成物及びその使用 Active JP6816098B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2015/087011 WO2017028025A1 (zh) 2015-08-14 2015-08-14 贻贝粘蛋白产品及其抑制粘膜炎症的应用
PCT/CN2016/095364 WO2017028777A1 (zh) 2015-08-14 2016-08-15 贻贝粘蛋白产品及其抑制粘膜炎症的应用

Publications (3)

Publication Number Publication Date
JP2019501108A JP2019501108A (ja) 2019-01-17
JP2019501108A5 JP2019501108A5 (enExample) 2019-09-19
JP6816098B2 true JP6816098B2 (ja) 2021-01-20

Family

ID=58050454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018501271A Active JP6816098B2 (ja) 2015-08-14 2016-08-15 粘膜炎症を抑制するためのイガイ接着タンパク質生成物及びその使用

Country Status (12)

Country Link
US (2) US10485848B2 (enExample)
EP (1) EP3335739B1 (enExample)
JP (1) JP6816098B2 (enExample)
KR (1) KR102708321B1 (enExample)
CN (1) CN108348636B (enExample)
AU (1) AU2016309397B2 (enExample)
CA (1) CA2995549C (enExample)
DK (1) DK3335739T3 (enExample)
MA (1) MA42629A (enExample)
MX (1) MX2018000654A (enExample)
SG (1) SG11201800578YA (enExample)
WO (2) WO2017028025A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201800440SA (en) 2015-07-20 2018-02-27 Bengt I Samuelsson Institute Of Life Science Res Mussel adhesive protein product and applications thereof in suppression of skin inflammations
MX2018000335A (es) 2015-07-20 2018-05-22 Bengt I Samuelsson Institute Of Life Science Res Aplicaciones de los productos de la proteina adhesiva del mejillon para el tratamiento y la prevencion de enfermedades relacionadas con la melanina.
WO2017011986A1 (zh) 2015-07-20 2017-01-26 赵兵 一种空气过滤装置
WO2017028025A1 (zh) 2015-08-14 2017-02-23 江阴市本特塞缪森生命科学研究院有限公司 贻贝粘蛋白产品及其抑制粘膜炎症的应用
CN110139662B (zh) * 2017-07-05 2022-03-18 江阴贝瑞森制药有限公司 肽的抗炎用途
MA52794A (fr) * 2018-05-28 2021-04-14 Jiangyin Usun Pharmaceutical Co Ltd Nouvelle utilisation pharmaceutique
WO2020182139A1 (zh) * 2019-03-12 2020-09-17 杭州英健生物科技有限公司 消化道黏膜保护胶
EP4028409A4 (en) * 2019-09-14 2023-10-11 EnliTISA (Shanghai) Pharmaceutical Co., Ltd. NEW PEPTIDES
CN114929726A (zh) * 2019-12-02 2022-08-19 艾缇亚(上海)制药有限公司 新肽及其在炎症治疗中的用途
KR102596264B1 (ko) 2020-11-30 2023-11-01 주식회사 바이오빛 기능성 펩티드가 결합된 생체적합 폴리펩티드를 포함하는 염증 질환의 억제용 조성물
CN114588267A (zh) * 2020-12-04 2022-06-07 江苏恒瑞医药股份有限公司 一种含酰胺类局部麻醉药的药物组合物
CN112695064B (zh) * 2021-02-01 2023-06-16 大连海洋大学 从海洋腹足类黏液中提取的抗肝癌和抗肝纤维化的低聚肽
JP2022172889A (ja) * 2021-05-07 2022-11-17 大和製罐株式会社 吐出容器入り薬液
CN115778926A (zh) * 2023-01-30 2023-03-14 南京天纵易康生物科技股份有限公司 一种含贻贝粘蛋白的可降解唇部护理贴剂及其制备方法
CN118059215B (zh) * 2024-01-23 2024-08-30 海南美安生物医药科技有限公司 一种妇科温敏型原位凝胶及其制备和应用
WO2025195444A1 (en) 2024-03-20 2025-09-25 Enlitisa (Shanghai) Pharmaceutical Co., Ltd. New use of peptides derived from vasoactive intestinal peptide
CN118236471B (zh) * 2024-03-21 2025-08-19 湖南天根乐微君科技有限公司 一种用于改善鼻炎症状和鼻腔清洗的组合物及其制备方法和应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
RU2043109C1 (ru) 1992-03-17 1995-09-10 Маина Александровна Бичурина Способ ингибиции вируса гриппа серотипов а и в
CN1112831A (zh) 1994-05-30 1995-12-06 乌力吉 含蜗牛提取液的长效多功能营养护肤水及其制法
NZ314867A (en) * 1997-05-21 1999-04-29 Mcfarlane Lab New Zealand Ltd Glucosamine and mussel extract compositions for use as anti-inflammatories
WO1999064580A1 (en) 1998-06-10 1999-12-16 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
US20020018787A1 (en) 1999-05-21 2002-02-14 Roger V. Kendall Methods and compositions for modulating immune response and for the treatment of inflammatory disease
EP1408999B1 (en) 1999-07-21 2008-03-12 Bomac Research Limited Compositions addressing inflammation and/or degenerative disorders
WO2001012146A1 (en) 1999-08-16 2001-02-22 Playtex Products, Inc. Sunscreen lotion or spray composition
US7074433B2 (en) 2001-03-30 2006-07-11 Council Of Scientific And Industrial Research Process for the cure and control of Diabetes mellitus using natural products from Perna viridis
US6770302B2 (en) 2001-03-30 2004-08-03 Department Of Biotechnology Indian green mussel (Perna viridis) as a source of anti-HIV activity
US6905710B2 (en) 2001-08-31 2005-06-14 Council Of Scientific And Industrial Research Pharmaceutical composition useful for inhibition of osteoclast formation and a process for the extraction of mussel hudrolysate from indian green mussel
US20060275370A1 (en) * 2002-07-25 2006-12-07 Yih-Lin Chung Method and compositions for treatment of epithelial damage
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
CA2553775A1 (en) * 2004-01-20 2005-08-11 Richard F. Harty Compositions and methods of treatment for inflammatory diseases
CN101348520B (zh) 2007-12-14 2011-10-12 顾铭 一种使用混合吸附色谱分离纯化贻贝粘蛋白的方法
CN101348518B (zh) 2007-12-14 2011-09-28 顾铭 一种使用羧甲基离子交换色谱纯化贻贝粘蛋白的方法
KR101022884B1 (ko) * 2009-06-12 2011-03-16 주식회사 원바이오젠 약물층을 포함하는 폴리우레탄 폼 드레싱제 및 그 제조방법
CN101585874B (zh) 2009-06-30 2012-08-22 江阴贝瑞森生化技术有限公司 一种使用盐析和透析分离纯化贻贝粘蛋白的方法
JP2012526155A (ja) 2009-08-25 2012-10-25 ポステック アカデミー−インダストリー ファンデーション イガイ接着蛋白質またはその変異体に陰イオン性高分子が含まれたコアセルベート
KR101147847B1 (ko) 2010-06-02 2012-05-24 건국대학교 산학협력단 패류 유래 기능성 펩티드의 분리 정제 방법 및 기능성 펩티드의 용도
CN101991840B (zh) 2010-09-26 2012-09-05 浙江海洋学院 抗前列腺癌贻贝酶解提取物的制备方法及应用
KR101384746B1 (ko) * 2011-08-24 2014-04-14 포항공과대학교 산학협력단 홍합 접착 단백질을 이용한 다양한 기능성 생체분자의 표면 고정화
CN102302417B (zh) 2011-09-13 2012-12-26 佛山市安安美容保健品有限公司 一种含有海洋生物活性物质的全效防晒乳液
WO2013143077A1 (zh) * 2012-03-28 2013-10-03 江阴贝瑞森生化技术有限公司 使用多模式色谱纯化贻贝粘蛋白的方法
WO2014186937A1 (zh) * 2013-05-20 2014-11-27 Gao Min 贻贝粘蛋白凝胶的制备方法、贻贝粘蛋白凝胶及其应用
CN103520766A (zh) * 2013-09-25 2014-01-22 高敏 贻贝粘蛋白液体产品、其制备方法及其应用
CN104323927A (zh) 2014-11-06 2015-02-04 济南星河康泰贸易有限公司 贻贝粘蛋白在制备皮肤美容化妆品上的应用
CN104645313A (zh) * 2015-01-28 2015-05-27 南京航空航天大学 一种修复止痒贻贝粘蛋白凝胶剂及其制备方法
CN104645320A (zh) 2015-01-28 2015-05-27 南京航空航天大学 一种创面修复用贻贝粘蛋白凝胶剂及其制备方法和应用
CN104857552B (zh) 2015-05-18 2018-08-10 赵明 一种止血贴及其制备方法
WO2017011986A1 (zh) 2015-07-20 2017-01-26 赵兵 一种空气过滤装置
SG11201800440SA (en) 2015-07-20 2018-02-27 Bengt I Samuelsson Institute Of Life Science Res Mussel adhesive protein product and applications thereof in suppression of skin inflammations
MX2018000335A (es) 2015-07-20 2018-05-22 Bengt I Samuelsson Institute Of Life Science Res Aplicaciones de los productos de la proteina adhesiva del mejillon para el tratamiento y la prevencion de enfermedades relacionadas con la melanina.
WO2017028025A1 (zh) 2015-08-14 2017-02-23 江阴市本特塞缪森生命科学研究院有限公司 贻贝粘蛋白产品及其抑制粘膜炎症的应用

Also Published As

Publication number Publication date
US11458190B2 (en) 2022-10-04
CN108348636B (zh) 2021-05-25
US20180243371A1 (en) 2018-08-30
SG11201800578YA (en) 2018-02-27
MA42629A (fr) 2018-06-20
WO2017028025A1 (zh) 2017-02-23
AU2016309397A1 (en) 2018-03-01
JP2019501108A (ja) 2019-01-17
US10485848B2 (en) 2019-11-26
KR102708321B1 (ko) 2024-09-23
DK3335739T3 (en) 2023-11-13
HK1257176A1 (en) 2019-10-18
AU2016309397B2 (en) 2020-10-22
CA2995549A1 (en) 2017-02-23
EP3335739B1 (en) 2023-10-04
CN108348636A (zh) 2018-07-31
EP3335739A4 (en) 2019-04-03
KR20180033517A (ko) 2018-04-03
US20200101135A1 (en) 2020-04-02
CA2995549C (en) 2024-01-02
MX2018000654A (es) 2018-07-06
WO2017028777A1 (zh) 2017-02-23
EP3335739A1 (en) 2018-06-20

Similar Documents

Publication Publication Date Title
JP6816098B2 (ja) 粘膜炎症を抑制するためのイガイ接着タンパク質生成物及びその使用
RU2403012C2 (ru) Мукоадгезивные ксилоглюкансодержащие препараты, полезные в медицинских устройствах и в фармацевтических препаратах
CN108348577B (zh) 贻贝粘蛋白产品及其抑制皮肤炎症的应用
CN105148253B (zh) 皮肤黏膜抗菌组合物
KR20100015767A (ko) 감염성 피부 및 점막 질환 치료약
CN106466454A (zh) 一种预防及治疗妇科炎症的凝胶剂
JP2022525509A (ja) 消化管粘膜用保護接着剤
US20160151436A1 (en) Treatment of Herpes, Pseudomonas, Staph, and Hepatitis
JP2001517621A (ja) 局所用非ステロイド系抗炎症剤組成物
WO2007014515A1 (en) Use of hydroxybenzoic acid ester and analogues for the manufacture of a mendicament for the prevention and treatment of virus infection
WO2017181978A1 (zh) 贻贝粘蛋白产品及其抑制血管炎症的应用
KR100963611B1 (ko) 알긴산류 화합물을 포함하는 점안용 조성물 및 그의제조방법
CN104983673B (zh) 抗hiv病毒的jb蛋白直肠凝胶制剂配方及制备方法
HK1257176B (en) Mussel adhesive protein product and the use thereof for the treatment of inflammation of the mucosa
RU2173155C1 (ru) Ранозаживляющий, противовоспалительный и противоинфекционный лекарственный препарат
RU2221562C1 (ru) Лекарственное средство и способ лечения генитального остроконечного кондиломатоза
CN100998576A (zh) 黄芩甙锌药物制剂
CN106798916A (zh) 一种治疗hpv感染的组合物及其应用
JP2006516964A (ja) 三つ葉型ドメイン含有ポリペプチドおよびその使用
WO2017028026A1 (zh) 贻贝粘蛋白用于粘膜的防护
CN108295038B (zh) 一种兽用肠溶组合物及其制备方法
CN116172904A (zh) 一种水包油体系的透明舌苔啫喱及其制备方法
CN117122584A (zh) 一种丁硼复方口溶膜及其制备方法
CN110859875A (zh) 一种苯妥英银复方药物及使用其制备的外用制剂
TW200410708A (en) Trefoil domain-containing polypeptides and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190805

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190805

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200728

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201021

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20201023

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20201201

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20201223

R150 Certificate of patent or registration of utility model

Ref document number: 6816098

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250